Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysis.

Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysis.

BACKGROUND:Stage IV non-small cell lung cancer (NSCLC) is associated with a five-year survival rate of around 1%. Treatment with Viscum album L. (VA) extracts has been shown to reduce chemotherapy (CTx)-related adverse events, decrease CTx dose reductions and improve quality of life in a number of c...

Full description

Bibliographic Details
Main Authors: Friedemann Schad, Anja Thronicke, Megan L Steele, Antje Merkle, Burkhard Matthes, Christian Grah, Harald Matthes
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC6110500?pdf=render

Internet

http://europepmc.org/articles/PMC6110500?pdf=render

Similar Items